Clinical trial • Phase I • Infectious Disease
HIV SOSIP v8.2 763 for HIV infection
Phase I trial of HIV SOSIP v8.2 763 for HIV infection. 12 participants.
Overview
- Trial Therapeutic Area
- Infectious Disease
- Trial Disease
- HIV infection
- Trial Stage
- Phase I
- Drug Modality
- Vaccine
Key dates
- Initial CTIS Submission Date
- 09-01-2025
- First CTIS Authorization Date
- 16-01-2025
Trial design
Phase I trial across 1 site in Spain.
- Target Sample Size
- 12
- Trial Duration For Participant
- 854
Recruitment
- Planned Sample Size
- 12
- Recruitment Window Months
- 28
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 12
Spain
- Earliest CTIS Part Ii Submission Date
- 08-01-2025
- Latest Decision Or Authorization Date
- 16-01-2025
- Processing Time Days
- 8
- Number Of Sites
- 1
- Number Of Participants
- 12
Sites
- Site Name
- Hospital Clinic De Barcelona
- Department Name
- HIV Unit
- Principal Investigator Name
- Josep Mallolas
- Principal Investigator Email
- mallolas@clinic.cat
- Contact Person Name
- Josep Mallolas
- Contact Person Email
- mallolas@clinic.cat
- Number Of Participants
- 12
Sponsor
Primary sponsor
- Full Name
- Consorcio Centro De Investigacion Biomedica En Red
- Organisation Type
- Laboratory/Research/Testing facility
- Country Of Registered Address
- Spain
Investigational products
- Investigational Product Name
- HIV SOSIP v8.2 763 Vaccine
- Active Substance
- HIV SOSIP v8.2 763
- Modality
- Vaccine
Related trials
Other published trials that may interest you.